About Synaptic Medical
Synaptic Medical is a Healthcare company based in Lake Forest (United States) founded in 2005 by Sophia Wang. Medical devices for cardiac arrhythmias and cardiovascular diseases are developed. Synaptic Medical has raised $60 million across 1 funding round from investors including SIG China and Huagai Capital. Its chief executive, as recorded, is Sophia Wang. Synaptic Medical offers products and services including Synaptic Platform. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its competitors include Orchestra BioMed and Inquis Medical; 2 of its 2 listed competitors have raised funding.
Company details
Developer of devices for the treatment of cardiac arrhythmias and cardiovascular diseases. The products developed are NaviEase (catheter with fluoroscopic visibility), AKS Needle (transseptal needle used with the catheter), Rithm Cool (irrigated tip ablation catheter), Rithm Rx (deflectable ablation catheter), and AquaSense (microinfusion irrigated tip ablation catheter).
- Headquarters Lake Forest, United States
- Founders Sophia Wang
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website synapticmed.com
- Social LinkedIn
- Total Equity Funding$60M (USD)
in 1 rounds
- Latest Funding Round$60M (USD), Series G
Mar 2021
- InvestorsSIG China
& 1 more
Products & Services of Synaptic Medical
Synaptic Medical offers a comprehensive portfolio of products and services, including Synaptic Platform.
Platform for holistic management of arrhythmia and cardiac diseases
Funding Insights of Synaptic Medical
Synaptic Medical has successfully raised a total of $60M through 1 strategic funding round. The most recent funding activity was a Series G round of $60 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $60M
- Total Rounds 1
- Last Round Series G — $60M
- First Round $60M
(Mar 2021)
- Investors Count 2
All 1 funding rounds of Synaptic Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2021 | $60M | Series G | – | Huagai Capital |
2 investors in total: 2 institutional.
Investors in Synaptic Medical
Synaptic Medical has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include SIG China and Huagai Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Tech companies in China are invested in by SIG China. | sig-china.com | Shanghai, China | ||
Private equity investment firm focused on multiple sectors | huagaicapital.com | Dongguan, China |
Investor details for Synaptic Medical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Synaptic Medical
1 people are tracked at Synaptic Medical (1 in leadership).
| Name | Role | Group |
|---|---|---|
Sophia Wang | Founder & CEO | Leadership |
Complete people profiles for Synaptic Medical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Synaptic Medical
2 dated milestones of Synaptic Medical across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Synaptic Medical is founded.
- Funding First funding round of $60.0M.
Competitors of Synaptic Medical
Synaptic Medical has 2 listed competitors in our database, 2 of them funded. They include Orchestra BioMed and Inquis Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| orchestrabiomed.com | 2017 | New Hope, United States | $205.88M | Medical devices for hypertension and atherosclerosis treatment are developed. | ||
| inquismedical.com | 2019 | Redwood, United States | $40M | Developer of medical device for the treatment of peripheral thrombectomy |
Detailed competitors of Synaptic Medical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Synaptic Medical
The website of Synaptic Medical (synapticmed.com) receives about 1.6K visits a month.
- Monthly visits1.6K
▼ 5.1% vs previous month
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as Synaptic Medical (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Synaptic Medical
Complete news archive for Synaptic Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Synaptic Medical
Synaptic Medical was founded in 2005 and raised its 1st funding round 16 years after it was founded.
Synaptic Medical is headquartered in Lake Forest, United States. It is registered at Lake Forest, California, United States.
Sophia Wang is the CEO of Synaptic Medical, as recorded in our data. They have also founded this company.
Synaptic Medical is a funded company, having raised a total of $60M across 1 funding round to date. The company's 1st funding round was a Series G of $60M, raised on Mar 2021.
Developer of devices for the treatment of cardiac arrhythmias and cardiovascular diseases. The products developed are NaviEase (catheter with fluoroscopic visibility), AKS Needle (transseptal needle used with the catheter), Rithm Cool (irrigated tip ablation catheter), Rithm Rx (deflectable ablation catheter), and AquaSense (microinfusion irrigated tip ablation catheter).
Synaptic Medical's top competitors include Orchestra BioMed and Inquis Medical.
Synaptic Medical offers Synaptic Platform.
Synaptic Medical has 2 investors. Key investors include SIG China, and Huagai Capital.